Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 539 of 1,261
  1. US 10100018

    Amide derivatives as lysophosphatidic acid receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  2. US 10100021

    Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

    Theravance Biopharma R&D IP, LLC · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  3. US 10100013

    Crystalline freebase forms of a biphenyl compound

    Theravance Biopharma R&D IP, LLC · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  4. US 10100312

    Compositions and methods for inhibiting expression of TMPRSS6 gene

    Alnylam Pharmaceuticals, Inc. · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  5. US 10099995

    Resveratrol esters

    Cole Research & Design, LLC · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  6. US 10098971

    Library of pH responsive polymers and nanoprobes thereof

    The Board of Regents of the University of Texas System · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  7. US 10098959

    Method for synthesis of reactive conjugate clusters

    Ionis Pharmaceuticals, Inc. · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  8. US 10098958

    Delivery of oligonucleotide functionalized nanoparticles

    Northwestern University · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  9. US 10098957

    Long-acting polymeric delivery systems

    Heron Therapeutics, Inc. · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  10. US 10098926

    Cell

    AUTOLUS LIMITED · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  11. US 10098925

    Protein SLURP-1 for use in the treatment of ocular diseases

    Brightpulse Holding Ltd. · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  12. US 10098889

    Complexes and salts of dihydropyrimidine derivatives and their application in pharmaceuticals

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  13. US 10098894

    Transdermal cream

    Compass Therapeutics LLC · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  14. US 10098893

    Methods of administering a trace amine-associated receptor 1 (TAAR1) agonist to patients having the minor allele of the single nucleotide polymorphism rs2237457

    Northwestern University · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  15. US 10098910

    Peroxide formulations and methods and applicators for using the same

    Aclaris Therapeutics, Inc. · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  16. US 10098878

    HIF-2α inhibitors for treating iron overload disorders

    The Board of Regents of the University of Texas System · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  17. US 10098839

    Hydrogel toxin-absorbing or binding nanoparticles

    The Regents of the University of California · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  18. US 10098540

    Hyperspectral imaging for detection of Parkinson's disease

    Regents of the University of Minnesota · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  19. US 10098379

    Device and method for simulating chemosensation of smoking

    Sentiens, LLC · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  20. US 10098372

    Whitening composition and the use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  21. WO 2018184678

    INHIBITEUR DES HDAC EN ASSOCIATION AVEC UN INHIBITEUR D'INTERACTION VEGF/VEGFR DESTINÉ À UN TRAITEMENT CONTRE LE CANCER BASÉ SUR LA NUMÉRATION PLAQUETTAIRE

    4SC AG [DE] · Granted Oct 11, 2018 · Expires Oct 6, 2038

    granted
  22. US 10093745

    Anti-CSPG4 fusions with interferon for the treatment of malignancy

    The Regents of the University of California · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted
  23. US 10092596

    Tungstate treatment of the dysbiosis associated with gastrointestinal inflammation

    The Regents of the University of California · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted
  24. US 10092580

    Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.